German firm gets EU patent for dsRNA modification

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process for the manufacturing of double-stranded RNA (dsRNA) bearing chemical...Read more

3SBio acquires patents for kidney failure drug

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2013

Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acquired patents for DJ5, a novel non-TZD PPARgamma agonist with potentia...Read more

Asia leverages on the biologics opportunity

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of active pharmaceutical ingredients, but they still need to build their s...Read more

Now remote monitoring service via smartphone

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2014

Singapore: AB SCIEX, life science analytical technologies provider, has launched StatusScope Remote Monitoring service, a configurable, real-time offering that supports most AB SCIEX mass s...Read more

Agilent launches biology solution for protein analysis

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Global supplier firm, Agilent Technologies, has launched QuikChange HT Protein Engineering System, a novel synthetic biology solutions for rational mutagenesis that creates libra...Read more

Belgian doctors develop new test tube baby system

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: As a solution to the lack of affordable test tube baby technology in developing countries, Belgian doctors have arrived at a solution. The researchers from Genk Institute for Fer...Read more

Monoclonal antibodies market set to grow in Europe

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies based therapeutics against conventional chemical drugs...Read more

Teva to acquire migraine drug firm at $825 mn

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2014

Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmaceutical, is set to acquire biotechnology company focused on treatment...Read more

Merck, Samsung to co-develop diabetes drug

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, have expanded their collaboration  to develop, manufacture ...Read more

H7N9 antibodies high among poultry workers'

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2014

Singapore: Serological tests conducted on poultry workers of southern Guangdong province city of Shenzhen China, showed evidence of asymptomatic or mild infections in poultry workers, furth...Read more

Quintiles to advise Ascendancy on pharma deals in China

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

Singapore: San Francisco-based Ascendancy Healthcare has tied up with Quintiles to get help from the contract research giant in order to leverage on China's growing pharma market. Quintile...Read more

Scientists trace origin of skin-deep immune cells

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful g...Read more

India's Polyclone collaborate with Greifswald Uni to engineer enzyme

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2014

Singapore: India based Polyclone, a biotech company with expertise in molecular, cell and computational biology has collaborated with the Dept. of Biotechnology & Enzyme Catalysis of th...Read more

GE launches modular pharma factory

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: GE Healthcare introduced KUBio, an innovative off-the-shelf, modular factory, designed to save manufacturers of biopharmaceuticals both time and money. KUBio's pre-made modules,...Read more

Green Cross builds $68 mn Thai plasma plant

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Feb, 2013

Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thailand. Green Cross, which signed the contract for the plant with the Th...Read more

Novozymes sales increased 7% in 2012

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

Singapore: Novozymes reported seven percent sales growth in 2012 when compared with 2011. EBIT increased by 17 percent, raising the EBIT margin to 24.4 percent. Net profit grew by 10 percen...Read more

Biologics: Indian companies address quality issues

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

In recent years, licensing and quality control for manufacturers and national regulatory authorities has become more complex. The National Institute of Biologicals (NIB) has been working si...Read more

3SBio, Selecta join hands to develop gout therapy

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2014

Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis. Pegsiti...Read more